論文・総説 - 平川　晃弘

分割表示  304 件中 261 - 280 件目  ／  全件表示 >>

  1. Yonemori K, Hirakawa A, Ando M, Hirata T, Shimizu C, Katsumata N, Tamura K, Fujiwara Y. Compliance with good clinical practice in oncology registration trials in Japan Annals of Oncology. 2011.06; 22 (6): 1451-1456.

  2. Hashimoto K, Yonemori K, Shimizu C, Hirakawa A, Yamamoto H, Ono M, Hirata T, Kouno T, Tamura K, Katsumata N, Ando M, Fujiwara Y. A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer Medical Oncology. 2011.06; 28 (2): 434-440.

  3. Hirata T, Yonemori K, Ando M, Hirakawa A, Tsuda H, Hasegawa T, Chuman H, Namikawa K, Yamazaki N, Fujiwara Y. Efficacy of taxane regimens in patients with metastatic angiosarcoma European Journal of Dermatology. 2011.06; 21 (4): 539-545.

  4. Yonemori K, Hirakawa A, Ando M, Hirata T, Shimizu C, Katsumata N, Tamura K, Fujiwara Y. Do investigators show selection biases when enrolling patients in phase I oncology registration trials? Journal of Geriatric Oncology. 2011.01; 2 (1): 25-30.

  5. Hashimoto K, Yonemori K, Katsumata N, Shimizu C, Hirakawa A, Hirata T, Kouno T, Tamura K, Ando M, Fujiwara Y. Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy Annals of Oncology. 2010.11; 21 (11): 2195-2200.

  6. Ando Y, Hirakawa A. . Discussion of “Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations”. Statistics in Biopharmaceutical Research. 2010.11; 2 (4): 462-465.

  7. Yonemori K, Hirakawa A, Komiyama N, Kouno T, Ando M, Fujiwara Y, Urano T, Akagawa H, Maruyama H, Toyoshima S. Participation of elderly patients in registration trials for oncology drug applications in Japan Annals of Oncology. 2010.10; 21 (10): 2112-2118.

  8. Ando Y, Hirakawa A, Uyama Y.. Adaptive clinical trials for new drug applications in Japan. European Neuropsychopharmacology. 2010.10; 21 (2): 175-179.

  9. Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hirakawa A, Ono M, Kouno T, Katsumata N, Ando M, Tamura K, Hasegawa T, Kinoshita T, Fujiwara Y. Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy Journal of Surgical Oncology. 2010.05; 101 (3): 222-227.

  10. Yonemori K, Kouno T, Ando M, Hirakawa A, Yamamoto H, Ono M, Hirata T, Shimizu C, Tamura K, Katsumata N, Fujiwara Y. Influence of suboptimal treatment in patients with mediastinal primary non-seminomatous germ cell tumor Oncology. 2010; 78 (1): 34-39.

  11. Hirata T, Shimizu C, Yonemori K, Hirakawa A, Kouno T, Tamura K, Ando M, Katsumata N, Fujiwara Y. Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer British Journal of Cancer. 2009.11; 101 (9): 1529-1536.

  12. Yonemori K, Ando M, Yunokawa M, Hirata T, Kouno T, Shimizu C, Tamura K, Katsumata N, Hirakawa A, Matsumoto K, Yamanaka Y, Arioka H, Fujiwara Y. Irinotecan plus carboplatin for patients with carcinoma of unknown primary site British Journal of Cancer. 2009.01; 100 (1): 50-55.

  13. Hirakawa A, Sato Y, Hamada C, Yoshimura I.. A new test statistic based on shrunken sample variance for identifying differentially expressed genes in small microarray experiments. Bioinformatics and Biology Insights. 2008.02; 29 (2): 145-156.

  14. Hirakawa A, Sato Y, Sozu T, Hamada C, Yoshimura I. Estimating the false discovery rate using mixed normal distribution for identifying differentially expressed genes in microarray data analysis. Cancer Informatics. 2007.02; 3 (6): 140-148.

  15. 平川 晃弘. 【臨床試験と観察研究の新機軸】特集に寄せて　総論　臨床研究方法論の新時代 Precision Medicine. 2024.02; 7 (2): 96-97. ( 医中誌 )

  16. 平川 晃弘. 【現代の臨床研究のための統計学2022-洗練された研究デザインと統計解析を理解してみよう】臨床試験の方法　生存時間データの統計解析 医学のあゆみ. 2022.01; 280 (5): 390-395. ( 医中誌 )

  17. 平川 晃弘, 佐藤 宏征, 井桁 正尭, 藤川 桂, 堀口 剛, 大門 貴志, 手良向 聡. 希少疾患領域の治験におけるベイズ流アプローチの利用可能性と留意事項 薬理と治療. 2021.09; 49 (Suppl.1): s72-s79. ( 医中誌 )

  18. 平川 晃弘, 佐藤 宏征. リハビリテーション職種が知っておくべき臨床統計　基礎から最新の話題まで　生存時間解析 Journal of Clinical Rehabilitation. 2021.08; 30 (9): 977-981. ( 医中誌 )

  19. 平川 晃弘. 【臨床研究における生物統計学の新たな貢献】がん臨床試験におけるマスタープロトコル Precision Medicine. 2020.11; 3 (13): 1194-1197. ( 医中誌 )

  20. 横井 克典, 服部 誠, 佐竹 勇紀, 平川 晃弘, 勝野 雅央. 健康診断の結果を用いたParkinson病の発症前バイオマーカーの検索 臨床神経学. 2020.11; 60 (Suppl.): S339. ( 医中誌 )

< 前のページ - 次のページ >

このページの先頭へ▲